首页> 外文期刊>Colorectal cancer. >Challenges in determining the benefits of restaging after chemoradiotherapy for locally advanced rectal cancer
【24h】

Challenges in determining the benefits of restaging after chemoradiotherapy for locally advanced rectal cancer

机译:确定局部晚期直肠癌放化疗后重新分期的益处面临的挑战

获取原文
获取原文并翻译 | 示例
       

摘要

Primary staging: Primary staging in rectal cancer is essential for determining the optimal treatment strategy and consists of local staging and screening for distant metastases. Local staging is important to determine the surgical approach and to identify individual risk factors for recurrence, such as depth of extramural spread, lymph node involvement, mesorectal fascia (MRF) involvement and extramural vascular invasion [1-4]. Patients with a low risk for recurrence can be treated by surgery alone, whereas patients with a high risk for recurrence must be treated with neoadjuvant (chemo-) radio-therapy (CTxRTx) to decrease the chance of local recurrence [5,6].
机译:主要分期:直肠癌的主要分期对于确定最佳治疗策略至关重要,包括局部分期和筛查远处转移。局部分期对于确定手术方法和确定复发的个体危险因素很重要,例如壁外扩散深度,淋巴结受累,直肠系膜筋膜(MRF)受累和壁外血管浸润[1-4]。复发风险低的患者可以单独手术治疗,而复发风险高的患者必须接受新辅助(化学)放疗(CTxRTx)治疗,以减少局部复发的机会[5,6]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号